These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 23184537

  • 41. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.
    Hart M, Nolte E, Wach S, Szczyrba J, Taubert H, Rau TT, Hartmann A, Grässer FA, Wullich B.
    Mol Cancer Res; 2014 Feb; 12(2):250-63. PubMed ID: 24337069
    [Abstract] [Full Text] [Related]

  • 42. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
    Xu B, Huang Y, Niu X, Tao T, Jiang L, Tong N, Chen S, Liu N, Zhu W, Chen M.
    Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
    [Abstract] [Full Text] [Related]

  • 43. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
    Yousef GM, Stephan C, Scorilas A, Ellatif MA, Jung K, Kristiansen G, Jung M, Polymeris ME, Diamandis EP.
    Prostate; 2003 Sep 01; 56(4):287-92. PubMed ID: 12858357
    [Abstract] [Full Text] [Related]

  • 44. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
    Paziewska A, Mikula M, Dabrowska M, Kulecka M, Goryca K, Antoniewicz A, Dobruch J, Borowka A, Rutkowski P, Ostrowski J.
    Prostate; 2018 Feb 01; 78(3):178-185. PubMed ID: 29226351
    [Abstract] [Full Text] [Related]

  • 45. miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.
    Lichner Z, Ding Q, Samaan S, Saleh C, Nasser A, Al-Haddad S, Samuel JN, Fleshner NE, Stephan C, Jung K, Yousef GM.
    J Pathol; 2015 Oct 01; 237(2):226-37. PubMed ID: 26011734
    [Abstract] [Full Text] [Related]

  • 46. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
    Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G.
    Am J Respir Cell Mol Biol; 2010 Mar 01; 42(3):312-9. PubMed ID: 19502386
    [Abstract] [Full Text] [Related]

  • 47. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
    Zhang Q, He XJ, Ma LP, Li N, Yang J, Cheng YX, Cui H.
    Zhonghua Zhong Liu Za Zhi; 2011 Dec 01; 33(12):885-90. PubMed ID: 22340095
    [Abstract] [Full Text] [Related]

  • 48. Widespread deregulation of microRNA expression in human prostate cancer.
    Ozen M, Creighton CJ, Ozdemir M, Ittmann M.
    Oncogene; 2008 Mar 13; 27(12):1788-93. PubMed ID: 17891175
    [Abstract] [Full Text] [Related]

  • 49. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ.
    Gut; 2009 Oct 13; 58(10):1375-81. PubMed ID: 19201770
    [Abstract] [Full Text] [Related]

  • 50. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG.
    Int J Biochem Cell Biol; 2012 Dec 13; 44(12):2321-32. PubMed ID: 22903020
    [Abstract] [Full Text] [Related]

  • 51. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T.
    Oncogene; 2012 Oct 11; 31(41):4460-71. PubMed ID: 22266859
    [Abstract] [Full Text] [Related]

  • 52. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M, Skrygan M, Georgas D, Sand D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.
    J Dermatol Sci; 2012 Dec 11; 68(3):119-26. PubMed ID: 23026055
    [Abstract] [Full Text] [Related]

  • 53. Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer.
    Barron N, Keenan J, Gammell P, Martinez VG, Freeman A, Masters JR, Clynes M.
    Prostate; 2012 Aug 01; 72(11):1193-9. PubMed ID: 22161972
    [Abstract] [Full Text] [Related]

  • 54. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ.
    Prostate; 2019 Jan 01; 79(1):88-95. PubMed ID: 30194772
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E, Pashaei E, Ahmady M, Ozen M, Aydin N.
    PLoS One; 2017 Jan 01; 12(6):e0179543. PubMed ID: 28651018
    [Abstract] [Full Text] [Related]

  • 57. MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
    Verdoodt B, Neid M, Vogt M, Kuhn V, Liffers ST, Palisaar RJ, Noldus J, Tannapfel A, Mirmohammadsadegh A.
    Int J Oncol; 2013 Jul 01; 43(1):307-14. PubMed ID: 23612742
    [Abstract] [Full Text] [Related]

  • 58. Expression of miR-126 and miR-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients.
    Qiang L, Hong L, Ningfu W, Huaihong C, Jing W.
    Int J Cardiol; 2013 Oct 03; 168(3):2082-8. PubMed ID: 23465244
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
    Fredsøe J, Rasmussen AKI, Mouritzen P, Borre M, Ørntoft T, Sørensen KD.
    Int J Cancer; 2019 Nov 01; 145(9):2558-2567. PubMed ID: 30903800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.